{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:50:31Z","timestamp":1787021431868,"version":"build-2736575974"},"reference-count":54,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,7,5]]},"DOI":"10.1248\/bpb.b25-00308","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T18:08:06Z","timestamp":1751652486000},"page":"972-985","source":"Crossref","is-referenced-by-count":4,"title":["Stimulation of <i>\u03b1<\/i>7 Nicotinic Acetylcholine Receptors by PNU282987 Demonstrates Efferocytosis-Like Activation and Neuroprotection in Human Models of Microglia and Cholinergic Neurons under the Pathophysiological Conditions of Alzheimer\u2019s Disease"],"prefix":"10.1248","volume":"48","author":[{"given":"Mari","family":"Sueyoshi","sequence":"first","affiliation":[{"name":"Joint Research Laboratory, Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Harada","sequence":"additional","affiliation":[{"name":"Joint Research Laboratory, Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Okawa","sequence":"additional","affiliation":[{"name":"Joint Research Laboratory, Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Matsuhara","sequence":"additional","affiliation":[{"name":"Joint Research Laboratory, Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momona","family":"Ando","sequence":"additional","affiliation":[{"name":"Joint Research Laboratory, Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riona","family":"Araki","sequence":"additional","affiliation":[{"name":"Joint Research Laboratory, Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Minote","sequence":"additional","affiliation":[{"name":"Joint Research Laboratory, Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Laboratory of Pathological Biochemistry, Division of Pathological Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Shimohama","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Sapporo Medical University, Sapporo 060\u20138543, Japan"},{"name":"Jiseikai Dementia Center, Itabashi-ku, Tokyo 175\u20130045, Japan"},{"name":"Jiseikai Hikarigaoka Hospital, Nerima-ku, Tokyo 179\u20130072, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Takata","sequence":"additional","affiliation":[{"name":"Joint Research Laboratory, Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607\u20138414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med.<\/i>, 8<\/b>, 595\u2013608 (2016).","DOI":"10.15252\/emmm.201606210"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tolar M, Hey J, Power A, Abushakra S. Neurotoxic soluble amyloid oligomers drive Alzheimer\u2019s pathogenesis and represent a clinically validated target for slowing disease progression. Int. J. Mol. Sci.<\/i>, 22<\/b>, 6355 (2021).","DOI":"10.3390\/ijms22126355"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Feng W, Zhang Y, Wang Z, Xu H, Wu T, Marshall C, Gao J, Xiao M. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer\u2019s disease mouse model with suppression of glymphatic clearance. Alzheimers Res. Ther.<\/i>, 12<\/b>, 125 (2020).","DOI":"10.1186\/s13195-020-00688-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Takata K, Ginhoux F, Shimohama S. Roles of microglia in Alzheimer\u2019s disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention. Biochem. Pharmacol.<\/i>, 192<\/b>, 114754 (2021).","DOI":"10.1016\/j.bcp.2021.114754"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) He C, Chen B, Yang H, Zhou X. The dual role of microglia in Alzheimer\u2019s disease: from immune regulation to pathological progression. Front. Aging Neurosci.<\/i>, 17<\/b>, 1554398 (2025).","DOI":"10.3389\/fnagi.2025.1554398"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Deczkowska A, Keren-Shaul K, Weiner A, Colonna M, Schwartz M, Amit I. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell<\/i>, 173<\/b>, 1073\u20131081 (2018).","DOI":"10.1016\/j.cell.2018.05.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Masuda T, Sankowski R, Staszewski O, Prinz M. Microglia heterogeneity in the single-cell era. Cell Rep.<\/i>, 30<\/b>, 1271\u20131281 (2020).","DOI":"10.1016\/j.celrep.2020.01.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Boada-Romero E, Martinez J, Heckmann BL, Green DR. The clearance of dead cells by efferocytosis. Nat. Rev. Mol. Cell Biol.<\/i>, 21<\/b>, 398\u2013414 (2020).","DOI":"10.1038\/s41580-020-0232-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tajbakhsh A, Read M, Barreto GE, \u00c1vila-Rodriguez M, Gheibi-Hayat SM, Sahebkar A. Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer\u2019s disease: pathological mechanisms and therapeutic outlooks. Eur. J. Pharmacol.<\/i>, 895<\/b>, 173873 (2021).","DOI":"10.1016\/j.ejphar.2021.173873"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM. The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. eBioMedicin<\/i>, 90<\/b>, 104511 (2023).","DOI":"10.1016\/j.ebiom.2023.104511"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Chen Y, Kou Y, Ni Y, Yang H, Xu C, Fan H, Liu H. Microglia efferocytosis: an emerging mechanism for the resolution of neuroinflammation in Alzheimer\u2019s disease. J. Neuroinflammation<\/i>, 22<\/b>, 96 (2025).","DOI":"10.1186\/s12974-025-03428-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Breese CR, Adams C, Logel J, Drebing C, Rollins Y, Barnhart M, Sullivan B, Demasters BK, Freedman R, Leonard S. Comparison of the regional expression of nicotinic acetylcholine receptor \u03b17 mRNA and [125<\/sup>I]-\u03b1-bungarotoxin binding in human postmortem brain. J. Comp. Neurol.<\/i>, 387<\/b>, 385\u2013398 (1997).","DOI":"10.1002\/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Court JA, Martin-Ruiz C, Graham A, Perry E. Nicotinic receptors in human brain: topography and pathology. J. Chem. Neuroanat.<\/i>, 20<\/b>, 281\u2013298 (2000).","DOI":"10.1016\/S0891-0618(00)00110-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Conejero-Goldberg C, Davles P, Ulloa L. Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration. Neurosci. Biobehav. Rev.<\/i>, 32<\/b>, 693\u2013706 (2008).","DOI":"10.1016\/j.neubiorev.2007.10.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Takata K, Kitamura Y, Saeki M, Terada M, Kagitani S, Kitamura R, Fujikawa Y, Maelicke A, Tomimoto H, Taniguchi T, Shimohama S. Galantamine-induced amyloid-\u03b2 clearance mediated via<\/i> stimulation of microglial nicotinic acetylcholine receptors. J. Biol. Chem.<\/i>, 285<\/b>, 40180\u201340191 (2010).","DOI":"10.1074\/jbc.M110.142356"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Takata K, Kitamura Y, Saeki M, Terada M, Kagitani S, Kitamura R, Fujikawa Y, Maelicke A, Tomimoto H, Taniguchi T, Shimohama S. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates A\u03b2 accumulation through suppression of neuronal \u03b3-secretase activity and promotion of microglial amyloid-\u03b2 phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer\u2019s disease. Neurobiol. Aging.<\/i>, 62<\/b>, 197\u2013209 (2018).","DOI":"10.1016\/j.neurobiolaging.2017.10.021"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakagawa M, Taniguchi Y, Senda S, Takizawa N, Ichisaka T, Asano K, Morizane A, Doi D, Takahashi J, Nishizawa M, Yoshida Y, Toyoda T, Osafune K, Sekiguchi K, Yamanaka S. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep.<\/i>, 4<\/b>, 3594 (2014).","DOI":"10.1038\/srep03594"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Fukuda A, Nakashima S, Oda Y, Nishimura K, Kawashima H, Kimura H, Ohgita T, Kawashita E, Ishihara K, Hanaki A, Okazaki M, Matsuda E, Tanaka Y, Nakamura S, Matsumoto T, Akiba S, Saito H, Matsuda H, Takata K. Plantainoside B in Bacopa monniera<\/i> binds to A\u03b2 aggregates attenuating neuronal damage and memory deficits induced by A\u03b2. Biol. Pharm. Bull.<\/i>, 46<\/b>, 320\u2013333 (2023).","DOI":"10.1248\/bpb.b22-00797"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Takata K, Kozaki T, Lee CZW, et al<\/i>. Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function. Immunity<\/i>, 47<\/b>, 183\u2013198.e6 (2017).","DOI":"10.1016\/j.immuni.2017.06.017"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Takata K, Nishimura K, Harada H, Iwasaki R, Ando M, Yamada S, Ginhoux F, Takata K. Analysis of A\u03b2<\/i>-induced neurotoxicity and microglial responses in simple two- and three-dimensional human iPSC-derived cortical culture systems. Tissue Cell<\/i>, 81<\/b>, 102023 (2023).","DOI":"10.1016\/j.tice.2023.102023"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sohma Y, Hirayama Y, Taniguchi A, Mukai H, Kiso Y. \u2018Click peptide\u2019 using production of monomer A \u03b2<\/i> from the O-acyl isopeptide: application to assay system of aggregation inhibitors and cellular cytotoxicity. Bioorg. Med. Chem.<\/i>, 19<\/b>, 1729\u20131733 (2011).","DOI":"10.1016\/j.bmc.2011.01.021"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Taniguchi A, Sohma Y, Hirayama Y, Mukai H, Kimura T, Hayashi Y, Matsuzaki K, Kiso Y. \u201cClick peptide\u201d: pH-triggered in situ production and aggregation of monomer A\u03b2<\/i>1-42. ChemBioChem<\/i>, 10<\/b>, 710\u2013715 (2009).","DOI":"10.1002\/cbic.200800765"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR. Mutant presenilins specifically elevate the levels of the 42 residue \u03b2<\/i>-amyloid peptide in vivo<\/i>: evidence for augmentation of a 42-specific \u03b3<\/i> secretase, Hum. Mol. Genet<\/i>., 12<\/b>, 159\u2013170 (2024).","DOI":"10.1093\/hmg\/ddh019"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science<\/i>, 330<\/b>, 841\u2013845 (2010).","DOI":"10.1126\/science.1194637"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Giacobini E, Cuello AC, Fisher A. Reimagining cholinergic therapy for Alzheimer\u2019s disease. Brain<\/i>, 145<\/b>, 2250\u20132275 (2022).","DOI":"10.1093\/brain\/awac096"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Wadman M. FDA no longer needs to require animal tests before human drug trials. Science<\/i>, 379<\/b>, 127\u2013128 (2023).","DOI":"10.1126\/science.adg6276"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Zushin PJH, Mukherjee S, Wu JC. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J. Clin. Invest.<\/i>, 133<\/b>, e175824 (2023).","DOI":"10.1172\/JCI175824"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nakano M, Tsuchida T, Mitsuishi Y, Nishimura M. Nicotinic acetylcholine receptor activation induces BACE1 transcription via<\/i> the phosphorylation and stabilization of nuclear SP1. Neurosci. Res.<\/i>, 203<\/b>, 28\u201341 (2024).","DOI":"10.1016\/j.neures.2023.12.002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease. Nat. Rev. Immunol.<\/i>, 20<\/b>, 254\u2013267 (2020).","DOI":"10.1038\/s41577-019-0240-6"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Romero-Molina C, Garretti F, Andrews SJ, Marcora E, Goate AM. Microglial efferocytosis: diving into the Alzheimer\u2019s disease gene pool. Neuron<\/i>, 110<\/b>, 3513\u20133533 (2022).","DOI":"10.1016\/j.neuron.2022.10.015"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Tanna CE, Goss LB, Ludwig CG, Chen PW. Arf GAPs as regulators of the actin cytoskeleton\u2014an update. Int. J. Mol. Sci.<\/i>, 20<\/b>, 442 (2019).","DOI":"10.3390\/ijms20020442"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Chan WWR, Li W, Chang RCC, Lau KF. ARF6-Rac1 signaling-mediated neurite outgrowth is potentiated by the neuronal adaptor FE65 through orchestrating ARF6 and ELMO1. FASEB J.<\/i>, 34<\/b>, 16397\u201316413 (2020).","DOI":"10.1096\/fj.202001703R"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Niedergang F, Colucci-Guyon E, Dubois T, Raposo G, Chavrier P. ADP ribosylation factor 6 is activated and controls membrane delivery during phagocytosis in macrophages. J. Cell Biol.<\/i>, 161<\/b>, 1143\u20131150 (2003).","DOI":"10.1083\/jcb.200210069"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Van Acker T, Tavernier J, Peelman F. The Small GTPase Arf6: an overview of its mechanisms of action and of its role in host-pathogen interactions and innate immunity. Int. J. Mol. Sci.<\/i>, 20<\/b>, 2209 (2019).","DOI":"10.3390\/ijms20092209"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Miki H, Suetsugu S, Takenawa T. WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J.<\/i>, 17<\/b>, 6932\u20136941 (1998).","DOI":"10.1093\/emboj\/17.23.6932"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Kitamura Y, Shibagaki K, Takata K, Tsuchiya D, Taniguchi T, Gebicke-Haerter PJ, Miki H, Takenawa T, Shimohama S. Involvement of Wiskott-Aldrich syndrome protein family verprolinhomologous protein (WAVE) and Rac1 in the phagocytosis of amyloid-\u03b2<\/i> (1\u201342) in rat microglia. J. Pharmacol. Sci.<\/i>, 92<\/b>, 115\u2013123 (2003).","DOI":"10.1254\/jphs.92.115"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Ikeda Y, Kawai K, Ikawa A, Kawamoto K, Egami Y, Araki N. Rac1 switching at the right time and location is essential for Fc\u03b3<\/i> receptor-mediated phagosome formation. J. Cell Sci.<\/i>, 130<\/b>, 2530\u20132540 (2017).","DOI":"10.1242\/jcs.201749"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Takata K, Kitamura Y, Yanagisawa D, Morikawa S, Morita M, Inubushi T, Tsuchiya D, Chishiro S, Saeki M, Taniguchi T, Shimohama S, Tooyama I. Microglial transplantation increases amyloid-\u03b2<\/i> clearance in Alzheimer model rats. FEBS Lett.<\/i>, 581<\/b>, 475\u2013478 (2007).","DOI":"10.1016\/j.febslet.2007.01.009"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Botelho F, Dubey A, Ayaub EA, Park R, Yip A, Humbles A, Kolbeck R, Richards CD. 1IL-33 mediates lung inflammation by the IL-6-type cytokine oncostatin M. Mediators Inflamm.<\/i>, 28<\/b>, 4087315 (2020).","DOI":"10.1155\/2020\/4087315"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Yuan Y, Zhang Q, Wu B, Huang T, Gong P, Xiang L. Oncostatin M regulates macrophages polarization in osseointegration via<\/i> yes-associated protein. Int. Immunopharmacol.<\/i>, 120<\/b>, 110348 (2023).","DOI":"10.1016\/j.intimp.2023.110348"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Shrivastava R, Asif M, Singh V, Dubey P, Ahmad Malik S, Lone MUD, Tewari BN, Baghel KS, Pal S, Nagar GK, Chattopadhyay N, Bhadauria S. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis. Cytokine<\/i>, 118<\/b>, 130\u2013143 (2019).","DOI":"10.1016\/j.cyto.2018.03.032"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Huang TC, Wu HL, Chen SH, Wang YT, Wu CC. Thrombomodulin facilitates peripheral nerve regeneration through regulating M1\/M2 switching. J. Neuroinflammation<\/i>, 17<\/b>, 240 (2020).","DOI":"10.1186\/s12974-020-01897-z"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Chang CH, Peng IC, Huang YH. Recombinant thrombomodulin domain 1 modulates macrophage polarization and enhances healing in corneal alkali burns. Invest. Ophthalmol. Vis. Sci.<\/i>, 66<\/b>, 21 (2025).","DOI":"10.1167\/iovs.66.1.21"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Ballinger EC, Ananth M, Talmage DA, Role LW. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron<\/i>, 91<\/b>, 1199\u20131218 (2016).","DOI":"10.1016\/j.neuron.2016.09.006"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Grothe M, Heinsen H, Teipel SJ. Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer\u2019s disease. Biol. Psychiatry<\/i>, 71<\/b>, 805\u2013813 (2012).","DOI":"10.1016\/j.biopsych.2011.06.019"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A. Nicotinic receptor stimulation protects neurons against \u03b2<\/i>-amyloid toxicity. Ann. Neurol.<\/i>, 42<\/b>, 159\u2013163 (1997).","DOI":"10.1002\/ana.410420205"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Guo J, Yang G, He Y, Xu H, Fan H, An J, Zhang L, Zhang R, Cao G, Hao D, Yang H. Involvement of \u03b17nAChR in the protective effects of genistein against \u03b2<\/i>-amyloid-induced oxidative stress in neurons via<\/i> a PI3K\/Akt\/Nrf2 pathway-related mechanism. Cell. Mol. Neurobiol.<\/i>, 41<\/b>, 377\u2013393 (2021).","DOI":"10.1007\/s10571-020-01009-8"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Duris K, Manaenko A, Suzuki H, Rolland WB, Krafft PR, Zhang JH. \u03b1<\/i>7 Nicotinic acetylcholine receptor agonist PNU-282987 attenuates early brain injury in a perforation model of subarachnoid hemorrhage in rats. Stroke<\/i>, 42<\/b>, 3530\u20133536 (2011).","DOI":"10.1161\/STROKEAHA.111.619965"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Ye L, Huang Y, Zhao L, Li Y, Sun L, Zhou Y, Qian G, Zheng JC. I\u03b2<\/i> and TNF-\u03b1<\/i> induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J. Neurochem.<\/i>, 125<\/b>, 897\u2013908 (2013).","DOI":"10.1111\/jnc.12263"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Noda M, Nakanishi H, Akaike N. Glutamate release from microglia via<\/i> glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience<\/i>, 92<\/b>, 1465\u20131474 (1999).","DOI":"10.1016\/S0306-4522(99)00036-6"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Wu Z, Tang W, Ibrahim FEEM, Chen X, Yan H, Tao C, Wang Z, Guo Y, Fu Y, Wang Q, Ge Y. A\u03b2<\/i> induces neuroinflammation and microglial M1 polarization via<\/i> cGAS-STING-IFITM3 signaling pathway in BV-2 cells. Neurochem. Res.<\/i>, 48<\/b>, 2881\u20132894 (2023).","DOI":"10.1007\/s11064-023-03945-5"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A. Alpha7 Nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A\u03b2<\/i>-amyloid-induced neurotoxicity. J. Biol. Chem.<\/i>, 276<\/b>, 13541\u201313546 (2001).","DOI":"10.1074\/jbc.M008035200"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Iwamoto K, Mata D, Linn DM, Linn CL. Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors. Neuroscience<\/i>, 237<\/b>, 184\u2013198 (2013).","DOI":"10.1016\/j.neuroscience.2013.02.003"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Bertrand D, Lee CHL, Flood D, Marger F, Donnelly-Roberts D. Therapeutic potential of \u03b17 nicotinic acetylcholine receptors. Pharmacol. Rev.<\/i>, 67<\/b>, 1025\u20131073 (2015).","DOI":"10.1124\/pr.113.008581"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/7\/48_b25-00308\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:46:30Z","timestamp":1751672790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/7\/48_b25-00308\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00308","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"article-number":"b25-00308"}}